Ontology highlight
ABSTRACT:
SUBMITTER: de Rocafiguera C
PROVIDER: S-EPMC10976151 | biostudies-literature | 2024 Feb
REPOSITORIES: biostudies-literature

de Rocafiguera Claudi C Belsa Blanca B Font-Bardia Mercè M Puigjaner Cristina C Serra Eduard E Cuartero-Albesa Ana M AM Puig de la Bellacasa Raimon R Borrell José I JI
Pharmaceuticals (Basel, Switzerland) 20240222 3
The impact of the crystalline or amorphous structure of a solid on the solubility and pharmacokinetic properties of a drug candidate is always considered by the pharmaceutical industry during the development of a new drug; however, it is not so frequently considered during the early drug discovery process by organic and medicinal chemists, particularly those working in academia. We want to share, as an example, the false negative obtained in the biological testing of a solid sample of a tyrosine ...[more]